$PHFR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHARMACEUTICAL FORMULATIONS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHARMACEUTICAL FORMULATIONS INC. Get notifications about new insider transactions in PHARMACEUTICAL FORMULATIONS INC for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 11 2005 | PHFR | PHARMACEUTICAL FOR ... | REISS MARTIN | VP, Manufacturing S ... | Option Exercise | M | 0.27 | 5,000 | 1,350 | 5,000 | |
Feb 11 2005 | PHFR | PHARMACEUTICAL FOR ... | REISS MARTIN | VP, Manufacturing S ... | Sell | S | 0.44 | 5,000 | 2,200 | 0 | 5 K to 0 (-100.00 %) |
Feb 11 2005 | PHFR | PHARMACEUTICAL FOR ... | REISS MARTIN | VP, Manufacturing S ... | Buy | M | 0.27 | 5,000 | 1,350 | 5,000 | 0 to 5 K |
Dec 15 2004 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Option Exercise | M | 0.23 | 75,000 | 17,250 | 0 | |
Dec 15 2004 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Buy | M | 0.23 | 75,000 | 17,250 | 230,000 | 155 K to 230 K (+48.39 %) |
Sep 02 2004 | PHFR | PHARMACEUTICAL FOR ... | INGRAM JAMES C | Chairman & CEO | Sell | S | 0.41 | 60,000 | 24,600 | 650,000 | 710 K to 650 K (-8.45 %) |
Aug 04 2004 | PHFR | PHARMACEUTICAL FOR ... | Bradley Brian | Exec VP Sales & Mar ... | Option Exercise | A | 0.52 | 100,000 | 52,000 | 100,000 | |
Jul 01 2004 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Sell | D | 0.50 | 15,000 | 7,500 | 155,000 | 170 K to 155 K (-8.82 %) |
Jun 16 2004 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Sell | D | 0.47 | 35,000 | 16,450 | 170,000 | 205 K to 170 K (-17.07 %) |
Feb 19 2004 | PHFR | PHARMACEUTICAL FOR ... | TOTH A ERNEST JR | Vice President, CFO | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Feb 18 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.60 | 10,000 | 6,000 | 25,000 | 15 K to 25 K (+66.67 %) |
Feb 18 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.60 | 5,000 | 3,000 | 15,000 | 10 K to 15 K (+50.00 %) |
Feb 18 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.60 | 5,000 | 3,000 | 10,000 | 5 K to 10 K (+100.00 %) |
Feb 13 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Option Exercise | A | 0.39 | 10,000 | 3,900 | 10,000 | |
Feb 13 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Grant | A | 0.00 | 5,000 | 0 | 59,600 | 54.6 K to 59.6 K (+9.16 %) |
Feb 13 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.40 | 1,600 | 640 | 54,160 | 52.6 K to 54.2 K (+3.04 %) |
Feb 13 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.40 | 20,000 | 8,000 | 53,000 | 33 K to 53 K (+60.61 %) |
Feb 13 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.40 | 13,000 | 5,200 | 33,000 | 20 K to 33 K (+65.00 %) |
Feb 13 2004 | PHFR | PHARMACEUTICAL FOR ... | BUHLER FRANK X | Director | Buy | P | 0.40 | 20,000 | 8,000 | 20,000 | 0 to 20 K |
Dec 30 2003 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Sell | S | 0.60 | 15,000 | 9,000 | 205,000 | 220 K to 205 K (-6.82 %) |
Dec 30 2003 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Sell | S | 0.60 | 15,000 | 9,000 | 205,000 | 220 K to 205 K (-6.82 %) |
Dec 30 2003 | PHFR | PHARMACEUTICAL FOR ... | CHEESMAN RAY W | Director | Sell | S | 0.60 | 15,000 | 9,000 | 205,000 | 220 K to 205 K (-6.82 %) |
Page: 1